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ABSTRACT We have developed six trans- 
genic lines of mice with constructs containing pre- 
sumptive 5‘ regulatory regions of carbonic anhy- 
drase I I  (CA 1 1 ) .  Four of the lines contained 1,100 
bases of the 5’ flanking region of the human CA II 
gene, and two transgenic lines resulted from a con- 
struct containing 500 bases of the 5‘ flanking re- 
gion of the mouse CA II gene. Tissue-specific ex- 
pression of the chloramphenicol acetyltransferase 
(CAT) gene was not obtained in any of the trans- 
genic lines. One of the transgenic lines was found 
to have high levels of expression of CAT in cere- 
bellum. This expression persisted through multiple 
generations and was independent of the parental 
origin of the transgene. O n  the assumption that the 
expression was due to the insertion of the trans- 
gene in or near a gene expressed normally in cer- 
ebellum, homozygous mice were bred for the 
transgenic insert to see if a mutation might have 
been induced. Homozygous mice were found and 
seemed to be normal in all aspects of their pheno- 
type studied. Thus, in this case, neither the insertion 
of the gene nor the ectopic expression of CAT 
seemed to be harmful to the animals. 
Key Words: Carbonic anhydrase II, Insertional 
genesis 
INTRODUCTION 
Carbonic anhydrase (CA) catalyzes the reversible 
hydration of carbon dioxide. Seven isozymes have so far 
been described in the multigene family (Tashian, 
1989). In mice, the CA I, CA 11, and CA I11 isozyme 
genes are tightly linked in the centromeric region of 
chromosome 3 (Eicher et al., 1976; Beechey et al., 
1989); in man, CA I, CA 11, and CA I11 are linked on the 
long arm of chromosome 8 (Edwards et al., 1986; 
Beechey et al., 1989). In humans, deficiency of CA I has 
been described with no clinical manifestations (Ken- 
dall and Tashian, 19771, whereas that for CA I1 has 
been found to produce pathological states of osteopetro- 
sis, renal tubular acidosis, and cerebral calcification 
(Sly et al., 1983). Lewis et al. (1988) have recently pro- 
duced a CA 11-deficient mouse by an induced mutation 
that resulted in mice with reduced growth and renal 
tubular acidosis. 
An interesting feature of the CA I1 gene in mammals 
is that it is expressed in almost all tissues, but only in 
a limited subset of cells (Tashian et al., 1984). Thus a 
variety of controlling elements may be expected to par- 
ticipate in the mechanism of regulation of CA I1 ex- 
pression. The nucleotide sequence surrounding the 
first and second exon of the human and mouse CA I1 
genes have been compared (Venta et al., 1985), with an 
overall percent identity of 81% and an even higher 
identity of 88% in the first exon. The region surround- 
ing the TATA box is well conserved (60%, -243 to 
TATA; 69%, TATA to ATG). The regions 700-800 bp 
on either side of the first exon are extremely G and C 
rich. Such islands have been shown to be associated 
with the 5’ regions of many mammalian genes. About 
90% of methylated cytosines in mammalian DNA are 
found in the CpG sequence. This methylation is impli- 
cated in the control of gene expression in higher eu- 
karyotes. A number of CCGCCC sequences have been 
found in the 5’ flanking regions. These sequences, first 
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Dosimetry of Integrations 
Dosage was calculated from absorption measure- 
ments on a Zeineh soft laser scanning densitometer 
Model SF-TRFF with the Zeineh videophoresis pro- 
gram software (Biomed Instruments, Inc., Fullerton, 
CAI in conjunction with an Apple IIc computer. The 
absorption of three different bands on the film probed 
with CAT were compared to the absorption of a single 
copy a-fetoprotein gene band (Camper and Tilghman, 
1989). The ratio of the CAT absorption over the a-fe- 
toprotein absorption was calculated to identify homozy- 
gotes. 
found near the origin of replication of SV40 and then 
reported on a number of genes (c-myc, alpha-globin, 
interleukin B, hydroxymethylglutaryl CoA-reductase), 
are important for the binding of a positive transcrip- 
tion factor called Spl. To study the role of these and 
other sequences in the tissue-specific and developmen- 
tal regulation of CA 11, we have been preparing trans- 
genic mice with CA I1 constructs. Although we have 
not yet identified the essential controlling elements for 
CA I1 expression, we have identified one transgenic 
insertion that induces ectopic expression of the trans- 
gene construct. However, this insertional event seems 
to be without harmful effect, even in homozygous con- 
dition. 
MATERIALS AND METHODS 
Generation of Transgenic Mice 
Mice of the SJL/J and C57B1/6J strains were pur- 
chased from the Jackson Laboratory and bred in our 
colony. Twenty-one-day-old F, females were used as 
donor animals for all experiments. They were primed 
with i.p. injections of 5 i.u. of pregnant male serum 
gonadotropin and with 5 i.u. human chorionic gonad- 
otrophin 44 h r  later and subsequently mated with F, 
males of the same strain. The following morning, one- 
cell embryos were collected from the plugged females 
in standard medium (Hogan et  al., 1986), and the DNA 
construct was injected into one of the pronuclei at a 
concentration of 1 ng/pl. After an  overnight culture at 
37°C in 5% COz in air, two-cell embryos were trans- 
ferred into pseudopregnant CD-1 recipients and al- 
lowed to go to term (Hogan et al., 1986). Offspring were 
weaned at 21 days of age and subjected to tail biopsy for 
DNA extraction and Southern analysis. Transgenic 
lines were established by breeding founder animals 
with F, mice. After a line was successfully established, 
the founders and offspring were sacrificed for assay of 
CAT activity as described below. 
Preparation of Constructs 
Construct pHCA-CAT containing 1,100 bases of the 
5' flanking region of human CA I1 gene ligated imme- 
diately upstream of the chloramphenicol acetyltrans- 
ferase (CAT) gene in the pSV2CAT plasmid (Gorman 
et al., 1982) was prepared as described (Shapiro et al., 
1987). The insert was purified by BamHI and SphI di- 
gestion of the construct. Agarose gel electrophoresis of 
the digestion mixture and extraction with NA45 DEAE 
membrane (Schliecher & Schuell) were subsequently 
performed, and the collected band was then resus- 
pended in TE for injection. Construct pMCA-CAT, con- 
taining approximately 500 bases of the 5' flanking re- 
gion of mouse CA I1 genes, was similarly introduced in 
the pSV2CAT plasmid as described. I t  was similarly 
purified by BamHI digestion and further treatment as 
described above. 
CAT Assays 
Assays for CAT were performed essentially accord- 
ing to a previously described protocol (Gorman et al., 
1982). Briefly, tissues were homogenized 1 : l  (wiv) with 
0.75 M Tris, pH 7.8. Insoluble debris was pelleted and 
the supernatant was heated to 60°C for 10 min (Crabb 
and Dixon, 1987). One hundred or twenty-five micro- 
grams of protein (Bradford, 1976) was incubated in the 
standard assay (Gorman et al., 1982) for 4 hr  at 37"C, 
and the amount of acetylated chloramphenicol was an- 
alyzed by thin-layer chromatography. Radioactive 
spots were cut from the plates, put in scintillation cock- 
tail, and counted. 
RESULTS 
Transgenic Lines 
We originally detected two founder animals positive 
for pMCA-CAT and four positive for pHCA-CAT. Of 
these, founder 585 for pHCA-CAT died before offspring 
were born. Southern analyses of the integrants and 
some of their offspring are shown in Figure 1. Founder 
129, and one of its offspring, and Founder 704, and two 
of its offspring, containing the pMCA-CAT construct, 
are shown after digestion of the DNA with BamHI, 
which does not cut inside the insert. Founder 129 
shows a complex pattern not easily explained by a sin- 
gle insertion site. Founder 704 shows a simpler pattern 
but the number of bands are also suggestive of a com- 
plex rearrangement. As seen by the control dosage 
lanes, these animals have multiple copies of the insert 
compatible with on the order of 10-12 in the case of 129 
and a roughly similar number in 704. Founders 133, 
586, and 349, with some of their offspring, containing 
the pHCA-CAT construct are also depicted in Figure 1 
after digestion with Sac1 and BamHI. Again, when the 
DNA is digested outside the pHCA-CAT insert, multi- 
ple bands suggesting a complex or multiple intergra- 
tion site pattern are seen in the case of the 133 and 586 
lines, although a simpler pattern is seen in the 349 
line. Approximate dosages suggest on the order of 10- 
15 copies of the 133 line with less, perhaps five to seven 
in the 586 line, and a similar number of copies in the 
349 line. 
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Fig. 1. Southern analysis of DNA from representative mice trans- 
genic for pMCA-CAT and pHCA-CAT probed with bacterial CAT in- 
sert. Lanes 1-5 BarnHI digestion of DNA from mice carrying pMCA- 
CAT: 1, founder 129; 2, offspring 311; 3, founder 704; 4, offspring 322; 
5, offspring 328. Lanes 6 7 :  Control lanes containing pMCA-CAT 
equivalent to one copy and five copies per genome. Lanes 9-17: SacI, 
BarnHI digestion of DNA from mice carrying pHCA-CAT 9, founder 
133; 10, offspring 375; 11, founder 586; 12, offspring 712; 13, offspring 
714; 14, tentative founder that did not transmit 344; 15, tentative 
founder that did not transmit 346; 16, founder 349. Lane 17: Control 
lane containing pHCA-CAT equivalent to one copy per genome. The 
filter was probed with an  oligolabeled pSV2-CAT probe. 
Expression of CAT Recorder Gene 
Multiple CAT assays were performed on founders 
andlor offspring to determine if appropriate tissue spe- 
cific expression was achieved. As can be seen in Table 
1, background levels of expression were found in al- 
most all cases (all the values of less than l% conver- 
sion) except for high levels in brains of line 586 and in 
lung of the single deceased founder 585. In all cases, we 
studied offspring that had both been transmitted 
through the male and through the female in case germ 
line imprinting (Surani et al., 1988) was responsible for 
the failure of expression. The high level of expression 
found in some mice from the 586 line, but not all, is 
depicted in Figure 2 along with some of the negative 
data for tissues such as lung and kidney, which would 
have also expressed if this was the regulation expected 
for CA 11, which is also expressed at high levels in lung 
and kidney. 
tegration patterns in the offspring. These two patterns 
and the typing for some animals are depicted in Figure 
3. As can be clearly seen, the complex B pattern con- 
tains almost all of the bands in the A pattern such that 
B is “dominant” to A. When the pedigree was followed 
for four generations with this in mind, it became ap- 
parent that the B pattern was associated with ectopic 
expression for CAT, whereas the A pattern was not 
(Fig. 4). This pedigree depicts only the positive ani- 
mals; the segregation ratio per offspring of a parent is 
indicated at the right of the individuals from the mat- 
ing (not all from one litter) and was not statistically 
different from 50%. When a line became “pure” for the 
A pattern, no brain expression was found whereas con- 
sistent ectopic expression for CAT was found in ani- 
mals having the B integrant whether this B integra- 
tion was heterozygous with a nonintegrant or A 
integration and whether it was transmitted through a 
male or a female. 
Segregation of Two Inserts in Line 586 
When we studied offspring in transgenic line 586 
that had integrated the pHCA-CAT construct, we were 
aware of the variable expression of the CAT recorder 
gene in brain and detected the segregation of two in- 
Anatomical Localization of Ectopic 
Brain Expression 
As can be seen in Figure 5 and Table 2, the high 
expression of the recorder molecule, CAT, was prima- 
rily limited to the cerebellum. Since values above 30% 
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TABLE 1. Summary of CAT Assays (% chloramphenicol converted to 
acetylated form) 
Line Tissue" 
























































































































































"b, Brain; h, heart; k, kidney; li, liver; lu, lung; s.i., small intestine; st, stomach; sp, spleen. 
Fig. 2. Chloramphenicol acetyltransferase assays of representative tissues from four mice of the 586B 
line. Left margin: control of purified bacterial CAT with nearly complete acetylation of the substrate. 
129: A 586A transgenic; 940, 941, and 942: 586B transgenics. The four mice are repeated in the same 
order with the lung and kidney samples. 
conversion are not linear with respect to amount of most likely to be contaminated with cerebellum in 
enzyme, due to substrate depletion, the relative these delicate dissections of fresh tissues. Thus, it 
amount of CAT activity in cerebellum is actually much seems likely that the ectopic expression was primarily 
greater than depicted. Slight to moderate levels were in the cerebellum with a level a t  least tenfold higher 
seen in tissues such as the medulla and pons, which are than in any other brain tissue. 
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Fig. 3. Southern analysis of D N A  digested with EcoRI from repre- 
sentative mice of the 586 line probed with bacterial CAT insert. A: A 
representative of the 586A insertion pattern; B: a representative of 
the 586B insertion pattern. 243: a newly typed A mouse; 246, 531, 
532, and 551: newly typed B mice. The few bands between 532 and 551 
represent D N A  from animal 547 that did not restrict well. 
Mice Homozygous for Integrant 586B 
We mated heterozygous mice from transgenic line 
586B with each other to try and determine if the inte- 
gration site leading to ectopic brain expression of chlor- 
amphenicol acetyltransferase would be associated with 
a phenotypic effect in homozygous mice. As can be seen 
in Figure 5 and Table 3, apparent homozygotes were 
obtained as determined by dosage for several of the 
bands in the integrants compared to  a single copy gene. 
Three of fourteen positive offspring appeared to be ho- 
mozygotes with ratios in the range of 1.7-2.6, with an 
average of 2.1 * 0.5. The number of apparent homozy- 
gotes was not statistically different from the number 
expected (U3, since homozygous normal are negative 
for the transgene and were not included). For compar- 
ison, the ratio in the parents and presumed heterozy- 
gous offspring ranged from 0.6 to 1.4, with an average 
of 1.0 * 0.2. Apparently homozygous mice had normal 
behavior in the cage and in the open field test (0.5 x 
0.75 m). They mated normally as evidenced by carrying 
litters to  term. Perhaps more surprising, even with the 
complex motor test of swimming, they appeared nor- 
mal. Thus, even homozygosity for this integrant lead- 
ing to ectopic expression seems to be without pheno- 
typic effect. 
DISCUSSION 
Transgenic mice formed by the insertion of DNA con- 
structs, first successfully accomplished by Gordon et al. 
(19801, have become the “gold standard” for studies of 
regulatory regions in mammalian DNA (reviewed in 
Gordon and Ruddle, 1985; Palmiter and Brinster, 
1986). Studies of mammalian regulatory regions using 
transgenic mice have shown considerable variation in 
the amounts and location of DNA sequences needed to 
achieve tissue-specific and developmental-appropriate 
regulation. In the case of pancreatic-specific expression 
of exocrine enzymes, only several hundred base pairs of 
5’ flanking sequence are needed to express elastase 
(Hammer et al., 1987) or amylase (Osborn et al., 1987) 
correctly. At the other extreme, to achieve high levels 
of expression of human P-globin in mice, the construct 
requires not only 5’, first intron, and 3’ sequences but 
DNAse I hypersensitive sites located approximately 15 
kb upstream and 10 kb downstream from the human 
p-globin structural locus (Grosveld et al., 1987). It is 
only when these DNAse I hypersensitive sites are in- 
cluded in the constructs that levels of P-globin expres- 
sion can be achieved in transgenic mice that are as 
high as those of the endogenous mouse p-globin gene. 
The preliminary results presented here suggest that 
CA I1 regulation may require sequence information in 
addition to 5’ flanking sequences. This is in marked 
contrast to the sequences needed to allow expression in 
cultured cells, where as little as 200 bp sufficed (Sha- 
piro et al., 1987). 
Transgenic mice, whether produced by virus or by 
DNA injection, sometimes carry new mutations. Early 
studies on the expression of T-antigen from SV40 con- 
structs integrated in mammalian cells showed great 
variability in the degree of expression between inde- 
pendent clones, presumably related to the different in- 
tegration sites (Hanahan et al., 1980). Jaenisch‘s group 
similarly demonstrated that the mice resulting from 
microinjection of cloned retroviral genes showed vari- 
able patterns of expression compatible with the inter- 
pretation that the chromosomal position of the viral 
genome influences its activation during development 
(Harbers et al., 1981). A lethal mutation in the colla- 
gen I gene occurred in one of their retroviral transgenic 
lines of mice, and this mutation has been of great in- 
terest because of the early embryonic death that re- 
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Fig. 4. Pedigree of the 586 line. Only mice positive for transgenes are depicted; the number positive/ 
number born is shown to the side of each subship (sometimes multiple litters). The nontransgenic mates 
(F,SJL/J x C57BL6/J) are not depicted. 
Fig. 5. Chloramphenicol acetyltransferase assays on dissected brain regions of a 586B mouse. Lane  1: 
Cerebellum. Lane 2 Cerebral cortex. Lane  3 Hippocampus. Lane 4: Hypothalamus. Lane 5: Medulla 
and pons. Lane 6 Midbrain. Lane 7 Thalamus. Lane 8: Negative control. Lane 9 Positive control of 
purified bacterial CAT. 
sults (Jaenisch et al., 1983; Harbers et al., 1984; 
Breindl et al., 1984). As the creation of transgenic mice 
by microinjection of DNA became more common, the 
first insertional mutations were found (Wagner et al., 
1983), and some interesting phenotypes, such as limb 
abnormalities, were described (Woychik et al., 1985). 
Although the first mutations found were recessive, 
dominant mutations have also been found. These have 
both been due t o  the insertional site (Wakosugi et al., 
1988) or due to the activity of the inserted transgene 
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TABLE 2. CAT Assays in Dissected Brains 
(% chloramphenicol converted to acetylated form) 
Animal 
Tissue 18705 ( P I  18743 (8) Mean 
Cerebellum 89.9 76.2 83.0 _._..~ 
Cortex 1.44 1.17 1.30 
Hippocampus 2.67 2.94 2.80 
Hypothalamus 7.42 3.63 5.52 
Midbrain 
Thalamus 
Medulla/pons 3.01 15.0 9.00 
2.65 - 
8.81 i 3.73 - 
- - Brainstem 1.11 
-CAT 0.20 0.23 0.22 
+CAT 99.7 99.4 99.6 
TABLE 3. Densitometric Studies of Transgene Dosage 
in 586B Heterozsglotes and Presumed Homozygotes 
a-Fetoprotein CAT I 
















6.0 t 0.4 
5.5 2 0.8 
3.1 f 0.6 
3.0 t 0.5 
5.5 t 9.5 
3.7 t 0.4 
9.0 2 0.7 
9.3 2 0.5 
8.0 f 0.7 
6.8 f 0.5 
2.4 2 1.1 
6.7 f 0.5 
5.6 t 0.4 
6.8 2 0.5 
5.4 f 0.5 
3.0 2 0.3 
7.8 2 0.2 
4.5 f 0.2 
4.8 2 0.3 
7.0 t 0.1 
9.8 t 0.8 
5.5 2 0.4 
9.6 t 0.7 
4.0 2 0.9 
8.5 f 0.9 
6.5 t 0.8 
737 5.1 f 0.5 9.7 2 0.8 
738 4.0 f 0.4 4.0 2 0.2 
740 4.7 ? 0.4 2.8 t 0.2 


















itself (Gordon, 1986). Male sterility has been a fairly 
common phenotype (Wilkie and Palmiter, 1987; Iwa- 
kwia et al., 1988). Our results are somewhat unusual 
in that we have integrated a transgene in a site that 
leads to activation of the recorder molecule but there 
seems to be no phenotypic effect of this insertion. If the 
insertion was into an expressed gene, i t  would be sur- 
prising if some effect on the gene’s expression was not 
found. However, it is possible that  the insertion event 
is upstream of an enhancer. Since enhancers have a 
nondirectional influence on gene expression, the inser- 
tion could result in no alteration of expression to a 
normal gene downstream of a putative enhancer. Ad- 
ditionally, however, it was surprising that the ectopic 
expression of CAT, a bacterial protein, had no effect on 
the animals. Presumably other cases will be found in 
which active gene integrants are without phenotype. 
Perhaps this is a measure of the redundancy of the 
genome. 
Fig. 6. Southern analyses of DNA digested with EcoRI from off- 
spring of a 586B x 586B cross probed with bacterial CAT insert. 712 
is a putative homozygote as indicated by dosimetry. 
It is interesting that the major CA isozyme normally 
found in mouse brain is CA 11. However, i t  is specifi- 
cally expressed in oligodendrocytes (Ghandour et al., 
1989), which are abundant in the cerebral cortex, cer- 
ebellum, and corpus callosum. Thus, the distribution of 
normal CA I1 is quite different from the ectopic expres- 
sion of CAT found with our insert. 
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